Published online Oct 15, 2020. doi: 10.4239/wjd.v11.i10.459
Peer-review started: April 24, 2020
First decision: June 15, 2020
Revised: July 8, 2020
Accepted: August 31, 2020
Article in press: August 31, 2020
Published online: October 15, 2020
High diabetes distress is associated with poorer diabetes outcomes. Technological interventions have been used as modern tools of communication to improve communication and can impact diabetes self-management, engagement and adherence. Understanding the impact of programs with technological interventions regarding disease management on type 2 diabetes distress bears clinical significance.
Review authors disagree about the benefits of this technology in type 2 diabetes distress. We systematically reviewed randomized controlled trials that studied the impact of technology interventions on type 2 diabetes distress.
The goal of this study is to provide comprehensive overview of the impact of technology interventions on type 2 diabetes distress.
We systematically searched MEDLINE, PubMed and EBSCO with the Boolean logic search terms were: (1) T2Diabetes; (2) Diabetes distress and (3) Technology OR mobile OR phone OR application OR web. We also systematically searched the reference lists of the included studies and relevant reviews.
We found nine full articles that met the inclusion criteria. Six out of nine articles showed that technology interventions had a positive impact on diabetes distress scale scores when compared with the initial data. Among these six articles, five showed a greater reduction in the diabetes distress scores from control interventions. Web-based interventions had good results when users received personalized feedback and routine caregiver support and attention.
Technology-based interventions have a positive impact on type 2 diabetes distress management, and programs that include routine caregiver support and attention show the best results.
These review findings could contribute to the development of new approaches on the elaboration of technological strategies to cope with type 2 diabetes distress and consequently improve treatment outcomes, resulting in patient well-being and better biological consequences in the management of type 2 diabetes.